Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life

Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life

Assessment

Interactive Video

Business

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the company's R&D spending, focusing on access and awareness programs for EpiPen. It highlights efforts to develop new devices based on patient feedback and improve the product's shelf life. The goal is to extend the shelf life to 24 months, with plans to submit findings to the FDA soon. Continued work on stability may further extend the shelf life beyond 24 months.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary focus of the company's R&D spending for EpiPen?

Access and awareness programs

Developing new flavors

Reducing production costs

Marketing campaigns

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the current shelf life of the EpiPen?

18 months

12 months

6 months

24 months

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the company's target shelf life for the EpiPen?

30 months

24 months

18 months

12 months

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

When does the company plan to submit their findings to the FDA?

Next year

In a few days

In a few weeks

In a few months

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What will the company continue to work on after submitting to the FDA?

New product lines

Cost reduction

Marketing strategies

Stability of the product